Warhound Secures $200M to Clone Engineered Service Dogs

For the first time, U.S. military and law enforcement units may soon deploy dogs that are not merely trained but genetically engineered for specific tactical advantages. This shift marks a new era in how working animals are sourced and equipped, moving beyond traditional breeding methods to address critical gaps in domestic supply. The initiative, which has emerged from stealth mode, promises to reduce the military's dependence on Europe for its canine workforce while enhancing the capabilities of these animals in high-risk environments.

The new company, named Warhound, has secured $200 million in funding to develop these specialized canines. The investment round values the startup at $1.2 billion. Key backers include Sequoia, 8VC, Corner Ventures, and In-Q-Tel, a venture firm with ties to U.S. intelligence agencies. This substantial capital injection signals strong confidence in the potential of combining biotechnology with advanced defense hardware to solve logistical and operational challenges in the field.

The venture is a joint effort involving Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. Lamm noted that he met Luckey approximately a year ago at a conference where the latter expressed a desire to improve the situation for military working dogs. Following their initial conversation, Lamm researched the breeding practices of working dogs and discovered that many fail to complete training due to inherited health issues, such as poor eyesight, cancer predispositions, hip dysplasia, or muscle atrophy. This research formed the basis for the new company's approach.

Currently, more than 80% of the U.S. military’s working dogs are imported from Europe, and fewer than half of those are deemed fit for service. Warhound aims to reverse this trend by creating a domestic supply of dogs engineered for health, longevity, and specific performance metrics. The company plans to use cell lines taken from top-performing breeds, specifically the Belgian Malinois and German Shepherd, to create a biobank. From there, scientists will edit genes to enhance traits like speed, agility, and olfactory sensitivity for tasks such as bomb detection, while removing genes associated with common ailments.

Anduril will play a crucial role by providing the software and hardware necessary to support these enhanced animals. The equipment will include items such as protection vests and goggles designed to improve situational awareness for both the dogs and their handlers. Lamm described the concept as adding technology "on top of the dog, not in the dog," suggesting that sensors in gear like bulletproof vests could transmit data back to handlers, allowing for better coordination and safety during operations.

The first batch of dogs is scheduled to be cloned and incubated shortly, with births expected in early 2027. The company hopes these animals will begin active service within two years. Viagen, another entity owned by Colossal, will handle the cloning process using technology that boasts a high success rate, which is currently used in Colossal's programs for protecting endangered species. Colossal will support Warhound by licensing its gene-editing technology, while retaining equity in the new venture. Notably, Luckey is a partner in the venture but does not hold equity.

While the company has not yet determined the price for these dogs, it anticipates selling to first responders, the Department of Defense, various military branches, and police forces. Lamm stated that the company has briefed numerous government groups on the business model. Regarding civilian safety, he assured that each dog will undergo standard military working dog training and be managed by its purchaser, ensuring they are integrated into existing operational frameworks.

To address ethical concerns, Warhound is collaborating with the American Humane Society to certify its training program. The goal is to ensure that these genetically modified animals are treated with the same standards of care as traditional service dogs. Additionally, the company hopes that retired Warhound dogs will be placed through the Society’s Military Working Dog Reunification Program, which finds homes for retired military canines.

The American Humane Society responded to the partnership by welcoming the collaboration, stating that they were pleased to have the "country’s first national humane organization, which is grounded in science and ethics, to have a seat at the table." The organization expressed its intent to work closely with Warhound and Colossal to guarantee that the animals in their care are treated humanely throughout their service lives.